Biocept Inc (NASDAQ: BIOC) Q3 2020 earnings call dated Nov. 12, 2020 Corporate Participants: Bruce Voss — Investor Relations Michael W. Nall — President and Chief Executive Officer Tim Kennedy — Chief Financial Officer and Senior Vice President of Operations Michael C. Dugan — Senior Vice President, Chief Medical Officer and Medical Director Analysts: Jason McCarthy — Maxim Group — Analyst Sally Yanchus — Brookline Capital Markets […]
“Biocept Inc (NASDAQ: BIOC) Q3 2020 earnings call dated Nov. 12, 2020 Corporate Participants: Bruce Voss — Investor Relations Michael W. Nall — President and Chief Executive Officer Tim Kennedy — Chief Financial Officer and Senior Vice President of Operations Michael C. Dugan — Senior Vice President, Chief Medical Officer and Medical Director Analysts: Jason McCarthy — Maxim Group — Analyst Sally Yanchus — Brookline Capital Markets […]
· November 13, 2020
Biocept Inc (NASDAQ: BIOC) Q3 2020 earnings call dated Nov. 12, 2020
Bruce Voss — Investor Relations
Michael W. Nall — President and Chief Executive Officer
Tim Kennedy — Chief Financial Officer and Senior Vice President of Operations
Michael C. Dugan — Senior Vice President, Chief Medical Officer and Medical Director
Jason McCarthy — Maxim Group — Analyst
Sally Yanchus — Brookline Capital Markets — Analyst
____
To read the full earnings call transcript, click here.
